Skip to main content
HealthReportedMediumDeveloping
4.8

Liège implant shows early promise in cluster headache pilot trial

A Liège-developed implant is being tested in the ONFIELD pilot study, the first human trial of this technology, targeting cluster headache patients unresponsive to existing treatments. Initial observations indicate reduced attack frequency with no serious adverse events reported, though the study is early-stage and small-scale. This matters as cluster headache is among the most severe pain conditions, and a viable neuromodulation option would fill a significant treatment gap.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Le Soirabout 6 hours agoBECredibility 28%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.3
Source

Related signals

8 found